Bio-FD&C Co (251120.KQ) Stock Price

Bio-FD&C Co Price

CLOSED
8,760.00
​
Market closed

Over the last 7 years Bio-FD&C Co grew revenue by 18.1% annually, reaching 19.18 B KRW. Earnings per share have grown at 49.7% per year over the last 7 years. For Bio-FD&C Co, the net margin of 34.8% is up versus 24.3% a few years ago. The consensus 12-month price target for Bio-FD&C Co is 19,482.00 KRW, about 122.4% above where the stock trades today. Of 5 analysts, 4 rate the stock a buy — an overall Buy consensus.

Bio-FD&C Co stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Bio-FD&C Co business model & stock analysis

Bio-FD&C Co., Ltd. develops bio and health technologies, focusing on manufacturing and selling soybean callus culture extract, clock stem cell, centella asiatica, callus extract, aloe barbadensis phytoplaceta extract, prunus mume phytoplacenta extract, secale cereale adventitious root extract, and acanthopanax koreanum adventitious root culture extract. These products serve as key materials for cosmeceuticals, health functional foods, and pharmaceuticals, targeting companies in the cosmetics, health supplement, and pharmaceutical industries. The company generates revenue through direct sales of these specialized extracts to manufacturers who incorporate them into their final products. The firm's product portfolio includes unique bioactive compounds like centella asiatica and prunus mume phytoplacenta extract, which are used in high-value applications within the cosmeceutical and pharmaceutical sectors. By supplying these specialized ingredients, Bio-FD&C Co., Ltd. caters to clients seeking natural, plant-based solutions for product development. Its focus on extract-based materials positions it as a supplier for companies developing innovative health and beauty products.

Frequently asked questions about Bio-FD&C Co

Analysts currently set an average price target of 19,482.00 KRW for the Bio-FD&C Co stock (median: 19,482.00 KRW), implying +122.4 % versus the latest price. The consensus is based on 5 analyst ratings.

5 analysts currently rate the Bio-FD&C Co stock: 4 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Bio-FD&C Co to generate revenue of 30.00 B KRW and earnings per share of 1,521.01 KRW.

Converted at the current exchange rate, the Bio-FD&C Co share trades at 5.83 EUR (8,760.00 KRW).

The expected revenue of Bio-FD&C Co is 30.00 B KRW. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Bio-FD&C Co is 12.97 B KRW. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Bio-FD&C Co is currently 5.76. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Bio-FD&C Co stock.

The price-to-sales ratio (P/S) of Bio-FD&C Co is currently 2.49. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Bio-FD&C Co stock.

The Eulerpool Quality Score for Bio-FD&C Co is 5/10.

The ISIN of Bio-FD&C Co is KR7251120002. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Bio-FD&C Co is 251120.KQ. The ticker symbol is used to trade Bio-FD&C Co shares on the stock exchange.

Fair ValueTerminal
8,234.40 KRW
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Biotechnology
Number of shares
Employees
Revenue per Employee
273.99 M KRW
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website biofdnc.com
Country
South Korea
Currency
KRW
Initial public offering
Feb 21, 2022
ISIN
KR7251120002
Cusip
Y0S14Z109
Market capitalization
74.71 B KRWLarge Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2026
5.76
P/Ee 2027
7.88
P/S
P/Se
2.49
EV/EBIT
11.95
P/B Ratio
1.07
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
9.55 %
Last updated Nov 11, 2026, 8:42 AM

Bio-FD&C Co Peer Group

Bio-FD&C Co FIGI

251120:KS · BBG00PF2MDQ2251120:KQ · BBG0149KH7V8

All fundamentals and in-depth analysis of Bio-FD&C Co

Our stock analysis for Bio-FD&C Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Bio-FD&C Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.